Didoné Filho Celso Nilo, Reginatto Cleiton Jonei, Ivantes Cláudia Alexandra Pontes, Strobel Rodrigo, Percicote Ana Paula, Petenusso Marcio, Sobreira da Silva Cicero Jordan R, Benjamim Cicero Jonas R, Radominski Rosana Bento
Hospital Nossa Senhora das Graças - Curitiba, Paraná, Brazil.
Universidade Estadual do Centro-Oeste, Departamento de Clínica Médica, Paraná, Brazil.
Obes Res Clin Pract. 2021 Mar-Apr;15(2):152-156. doi: 10.1016/j.orcp.2021.02.004. Epub 2021 Feb 27.
Obesity is a multifactorial disease characterized by fat accumulation, usually associated with non-alcoholic fatty liver disease, which can lead to advanced fibrosis or even cirrhosis. Bariatric surgery (BS) is a treatment approved for weight loss in morbidly obese patients. However, complications from this modality of treatment have been reported and liver cirrhosis connotes more risk procedure.
Evaluate non-invasive methods transient elastography (THE) and scores to establish the degree of liver fibrosis in patients submitted to BS, comparing their performance with liver histology.
We calculated liver fibrosis by non-invasive scores AST to platelet ration index (APRI), fibrosis-4 (FIB-4) and non-alcoholic fatty liver disease (NAFLD) score and THE before and 6 months after the bariatric surgery. The results were compared to liver histology.
We included 85 patients, 69.4% females, with a mean age of 36 years, with a mean body mass index (BMI) of 41 kg/m. The non-invasive scores were able to exclude clinically significant fibrosis in 85.9% (APRI) and advanced fibrosis in 96.5% (FIB-4) and 51.8% (NAFLD score). When comparing with the histological findings, the correlation with elastography was 45.9% for the same degree of fibrosis, with high negative predictive value (94.4%) in pre-surgical analysis. In the post-surgical analysis, the correlation with histology was 69.4% for THE and the negative predictive value to exclude clinically significant fibrosis was 98.5%.
THE showed low correlation with histology in the pre-surgical analysis. All the methods had better results in post bariatric evaluation comparing with pre-bariatric data and the non-invasive FIB-4 score showed the best of them.
肥胖是一种多因素疾病,其特征为脂肪堆积,通常与非酒精性脂肪性肝病相关,后者可导致晚期纤维化甚至肝硬化。减重手术是一种被批准用于治疗病态肥胖患者体重减轻的方法。然而,这种治疗方式的并发症已有报道,而肝硬化意味着手术风险更高。
评估非侵入性方法瞬时弹性成像(THE)和评分,以确定接受减重手术患者的肝纤维化程度,并将其性能与肝组织学进行比较。
我们通过非侵入性评分天门冬氨酸氨基转移酶与血小板比值指数(APRI)、纤维化-4(FIB-4)和非酒精性脂肪性肝病(NAFLD)评分以及在减重手术前和术后6个月的THE来计算肝纤维化。将结果与肝组织学进行比较。
我们纳入了85例患者,其中69.4%为女性,平均年龄36岁,平均体重指数(BMI)为41kg/m。非侵入性评分能够在85.9%(APRI)的患者中排除临床显著纤维化,在96.5%(FIB-4)和51.8%(NAFLD评分)的患者中排除晚期纤维化。与组织学结果相比,对于相同程度的纤维化,弹性成像的相关性为45.9%,在术前分析中具有较高的阴性预测值(94.4%)。在术后分析中,THE与组织学的相关性为69.4%,排除临床显著纤维化的阴性预测值为98.5%。
术前分析中THE与组织学的相关性较低。与术前数据相比,所有方法在减重术后评估中均有更好的结果,且非侵入性FIB-4评分表现最佳。